scholarly journals Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer

2019 ◽  
Author(s):  
Haiying Jiang ◽  
Mei Zhu ◽  
Yanfang Li ◽  
Qian Li
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Survival Rates ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Tki Treatment ◽  
Egfr Tki ◽  
Exon 19

Possible differential EGFR-TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancer

Lung Cancer ◽  
2014 ◽  
Vol 86 (2) ◽  
pp. 213-218 ◽  
Author(s):  
Toshihiko Kaneda ◽  
Akito Hata ◽  
Hiromi Tomioka ◽  
Kosuke Tanaka ◽  
Reiko Kaji ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Mutant ◽  
Egfr Tki ◽  
Exon 19

scholarly journals ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non–Small Cell Lung Cancer

2020 ◽  
Vol 26 (9) ◽  
pp. 2244-2256 ◽  
Author(s):  
Naoko Okura ◽  
Naoya Nishioka ◽  
Tadaaki Yamada ◽  
Hirokazu Taniguchi ◽  
Keiko Tanimura ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Adaptive Resistance ◽  
Tki Treatment ◽  
Egfr Mutated ◽  
Egfr Tki

scholarly journals Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment

2020 ◽  
Vol 11 (8) ◽  
pp. 2188-2195
Author(s):  
Norimitsu Kasahara ◽  
Hisao Imai ◽  
Ichiro Naruse ◽  
Yusuke Tsukagoshi ◽  
Mie Kotake ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Score ◽  
Glasgow Prognostic Score ◽  
Small Cell ◽  
Small Cell Lung ◽  
Tki Treatment ◽  
Egfr Tki
Sign in / Sign up

Export Citation Format

Share Document